¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѳ»ºÐºñÇÐȸ SICEM 2024(1ÀÏÂ÷) : 2024-04-11

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѳ»ºÐºñÇÐȸ SICEM 2024(1ÀÏÂ÷) : 2024-04-11
±³À°ÀÏÀÚ : 2024-04-11
±³À°Àå¼Ò : ±×·£µå ¿öÄ¿Èú ¼­¿ï

±³À°ÁÖÁ¦ : SICEM 2024(1ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ
´ã´çÀÚ : ¹Ú¼öºó
¿¬¶ôó : 02-2038-0072  

À̸ÞÀÏ : endo@endocrinology.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 1500¸í
Èñ¸ÁÆòÁ¡ : 3Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 350,000¿ø  

ºñ°í [ÇöÀåµî·Ï]ºñȸ¿ø - Àü¹®ÀÇ: 350,000¿ø / Àü°øÀÇ: 175,000¿ø / ±âŸ: 250,000¿øȸ¿ø - Àü¹®ÀÇ: 250,000¿ø / Àü°øÀÇ: 125,000¿ø / ±âŸ: 200,000¿ø[»çÀüµî·Ï]ºñȸ¿ø - Àü¹®ÀÇ: 250,000¿ø / Àü°øÀÇ: 125,000¿ø / ±âŸ 200,000¿øȸ¿ø - Àü¹®ÀÇ: 200,000¿ø / Àü°øÀÇ: 100,000¿ø / ±âŸ 150,000


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 11ÀÏ Room5 14:00~14:20 Comparative analysis of hormonal receptor-expressing neurons in the area postrema across species Jung Tae Kim(KAIST Korea)

±³À°½Ã°£ 04¿ù 11ÀÏ Room5 14:20~14:40 Maintenance of body weight by GIRK2 potassium channels Youjin Oh(KAIST Korea)

±³À°½Ã°£ 04¿ù 11ÀÏ Room5 14:40~15:00 Crosstalk between neuronal mitochondria and microglia derives hypoglycemia-induced memory dysfunction Jae-Young Joo(Seoul National University Korea)

±³À°½Ã°£ 04¿ù 11ÀÏ Room5 15:00~15:20 GLP-1 modulate hypothalamic circuits for cognitive satiation Kyu Sik Kim(Seoul National University Korea)

±³À°½Ã°£ 04¿ù 11ÀÏ Room5 15:20~15:40 RNA binding protein HuR is required for brown fat thermogenesis Kun-Young Park(KAIST Korea)

±³À°½Ã°£ 04¿ù 11ÀÏ Room5 15:40~16:00 Adipose tissue dendritic cell regulates glucose homeostasis in obesity via incretin action Shindy Soedono(Soonchunhyang University Korea)

±³À°½Ã°£ 04¿ù 11ÀÏ Room3 16:30~16:45 Unveiling the mystery: an Introduction to multiple endocrine neoplasia You-Bin Lee(Sungkyunkwan University Korea)

±³À°½Ã°£ 04¿ù 11ÀÏ Room3 16:45~17:10 Dual perspectives on MEN type 1 – a clinician and patient Mark Lewis(Salt Lake Clinic Internal Medicine USA)

±³À°½Ã°£ 04¿ù 11ÀÏ Room3 17:10~17:30 Living with MEN type 2 – a personal history and insight from AMEND Jo Grey(Association For Multiple Endocrine Neoplasia Disorders (AMEND) UK)

±³À°½Ã°£ 04¿ù 11ÀÏ Room3 17:30~17:45 MEN in South Korea: a deep dive into epidemiology and clinical outcomes Kyoung Jin Kim(Korea University Korea)

Åä·Ð 04¿ù 11ÀÏ Room3 17:45~18:00 Åä·Ð ( )

±³À°½Ã°£ 04¿ù 11ÀÏ Room4 16:30~16:50 Ecological effects of microplastics and its implications for human health Youn-Joo An(Konkuk University Korea)

±³À°½Ã°£ 04¿ù 11ÀÏ Room4 16:50~17:10 Exposure to microplastic through food and toxicological effect Ju Hee Kim(Kyung Hee University Korea)

±³À°½Ã°£ 04¿ù 11ÀÏ Room4 17:10~17:30 Microplastics: rethinking the current paradigm Duk-Hee Lee(Kyungpook National University Korea)

±³À°½Ã°£ 04¿ù 11ÀÏ Room4 17:30~17:50 Analysis of microplastics in biological samples Jaehak Jung(Korea Institute of Analytical Science and Technology Korea)

Åä·Ð 04¿ù 11ÀÏ Room4 17:50~18:00 Åä·Ð ( )

±³À°½Ã°£ 04¿ù 11ÀÏ Room5 16:30~17:00 Promoting international network for clinical trial Nakatani Daisuke(Osaka University Japan)

±³À°½Ã°£ 04¿ù 11ÀÏ Room5 17:00~17:30 Smart connected health: artificial intelligence and advanced data science Seung-Min Park(Nanyang Technological University Singapore)

±³À°½Ã°£ 04¿ù 11ÀÏ Room5 17:30~18:00 Treating hypothyroidism precisely Sihoon Lee(Gachon University Korea)

±³À°½Ã°£ 04¿ù 11ÀÏ Room4 19:30~20:30 " Early intervention of type 2 diabetic patient considering cardio-renal-metabolic system" Jae-Hyung Cho(The Catholic University of Korea Korea)

±³À°½Ã°£ 04¿ù 11ÀÏ Room5 19:30~20:00 Optimal diabetes management with evidence-based Dughyun Choi(Soonchunhyang University Korea)

±³À°½Ã°£ 04¿ù 11ÀÏ Room5 20:00~20:30 Gemigliptin + dapagliflozin: optimal combination for holistic diabetes treatment Soree Ryang(Pusan National University Korea)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѳ»ºÐºñÇÐȸ SICEM 2024(1ÀÏÂ÷) : 2024-04-11""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024 ´ëÇѳ»½Ã°æ·Îº¿¿Ü°úÇÐȸ Ãá°è Çмú´ëȸ ¹× 14ȸ ±¹Á¦½ÉÆ÷Áö¿ò (KSERS 2024)(1ÀÏÂ÷) : 2024-04-11
´ÙÀ½±Û 2024³â ´ëÇѸ鿪ÇÐȸ 50Áֳ⠱â³ä Ãá°èÇмú´ëȸ 1ÀÏÂ÷ : 2024-04-11
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20664 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ)¼Ò¾Æû¼Ò³â°ú Çù·ÂÀÇ»ç Áý´ãȸ : 2024-05-28 0 16 2024-05-10
20663 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ Á¦1ȸ ÃÊÀ½ÆÄ ½ÇÀü ¾ÆÄ«µ¥¹Ì : 2024-05-27 0 14 2024-05-10
20662 ¼­¿ï ´ëÇѿ°èÁٱ⼼Æ÷Àç»ýÀÇÇÐȸ - Á¦20ȸ Ãá°èÇмú´ëȸ (ÇÏÀ̺긮µå) : 2024-05-26 0 11 2024-05-10
20661 ºÎ»ê ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ºÎ¿ï°æÁöȸ 5¿ù ¿¬¼ö°­Á : 2024-05-26 0 6 2024-05-10
20660 ¼­¿ï ´ëÇѽŰæ±Ù°ñ°áÃÊÀ½ÆÄÇÐȸ Á¦1ȸ ÇÚÁî¿Â ¿öÅ©¼ó : 2024-05-25 0 16 2024-05-10
20659 ´ëÀü ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ 2024 Áöȸ½ÉÆ÷Áö¾ö-´ëÀüÃæ³² : 2024-05-25 0 3 2024-05-10
20658 ºÎ»ê ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-25 0 7 2024-05-10
20657 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø The 1st International Symposium on Precision Oncology in Breast Cancer : 2024-05-25 0 11 2024-05-10
20656 ¼­¿ï (¿Â¶óÀÎ)2024³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦1Â÷ FLS ÄÚµð³×ÀÌÅÍ ¿öÅ©¼ó : 2024-05-24 0 9 2024-05-10
20655 ¼­¿ï Á¦ 66ȸ Çѱ¹Ç×°ø¿ìÁÖÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-24 0 5 2024-05-10
20654 ´ëÀü °ø°ø±â°ü ÀçÁ÷ÀÇ»ç Ãá°è Çмú´ëȸ (2ÀÏÂ÷) : 2024-05-24 0 4 2024-05-10
20653 ºÎ»ê ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ(1ÀÏÂ÷) : 2024-05-24 0 5 2024-05-10
20652 ¼­¿ï Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦ 44 Â÷ KSTH Ãá°èÇмú´ëȸ : 2024-05-24 0 6 2024-05-10
20651 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-°³¿ø°¡¿¡¼­ ÀÇ·ÚµÈ ÀÌ°ú Áúȯ : 2024-05-23 0 7 2024-05-10
20650 °æ±â Çϳ²½ÃÀÇ»çȸ¿¬¼ö°­ÁÂ(¸¸¼º±âħ, ºÒ¸éÁõ) : 2024-05-23 0 3 2024-05-10
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷